Friday January 24, 2020

Only these 7 pasta brands have been given green chit by FSSAI after Maggi mess

0
//

9682763081_542a55fb84_o

New Delhi: Instant noodles and pastas with taste-makers of only seven companies are allowed to be sold in India, the food safety watchdog said on Monday, while also ordering tests on all approved variants and calling for the remaining “illegal” ones to be destroyed.

The seven companies that have approvals for their variants of instant noodles and pastas with taste-makers are:

FSSAI Approved Pastas & Noodles Companies Are:

  • Ruchi International (Koka)
  • CG Foods (Wai Wai)
  • Glaxosmithkline (Foodles)
  • Nestle (Maggi)
  • AA Nutrition (Yummy)
  • Indo Nisin (Top Ramen)
  • ITC (brand not specified)

“The safety of all other products in these categories has not been assessed as per the product approval procedures. As such, the same are unauthorized and illegal and cannot be intended for human consumption,” said a letter from the Food Safety and Standards Authority of India (FSSAI).

Ordering tests on all the approved varieties, the letter written by chief executive Yudhvir Singh Malik to all the commissioners of food safety said that as far as all the remaining food products are concerned, they are advised to “ensure such products are recalled, removed from the market and destroyed.”

Speaking to IANS, the top food safety officer said tests on Nestle’s Maggi and some other similar products had raised serious health concerns and thus it was thought fit to conduct tests on all similar products for which approvals had been granted.

Following tests on some samples of Maggi, the watchdog on Friday had ordered the recall of all the nine variants of Maggi pan-India, and had asked Nestle to halt its production and exports. It had also issued a similar order on Nestle’s oats noodles and taste-maker.

While Nestle continues to contend that its noodles were safe for humans and that the levels of lead were within permissible limits – as opposed to the findings of some tests that purportedly indicated otherwise, several states also became pro-active by issuing their own ban orders.

“Overseas and local manufacturers would be treated equally. More noodle brands including pasta and macaroni products will also start getting tested this week,” Malik said.

On being asked if the brand ambassadors could be taken to task, he said: “As of now, we are not considering any action.”

The regulator also detailed the process involved in the recall of food products.

“Ideally, consumers should be able to return the product at the retail outlet and get their money back if they have the bill with them. It is also Nestle’s responsibility to let the consumers return their products, if they have kept the bill with them,” he said.

The regulator also plans to post a list of all approved noodle products on its web site and advise the state authorities to test them. “We understand Delhi, Gujarat and Tamil Nadu have already started testing other brands. We will list all the approved noodle products soon.”

He further said that Nestle had been asked to give the regulator an update on compliance first after three days and then regularly until the end. “Because we understand that it could take 10 days or more, we will be taking regular progress reports from the company,” Malik said.

-IANS

Next Story

Here’s How Belly Fat Increases the Risk of Heart Attack

Belly fat may lead to multiple heart attacks

0
Heart Attack
Heart attack survivors who carry excess fat around their waist are at increased risk of another heart attack. Pixabay

Heart patients, please take note, here’s a new health news. Researchers have found that heart attack survivors who carry excess fat around their waist are at increased risk of another heart attack.

“Abdominal obesity not only increases your risk for a first heart attack or stroke, but also the risk for recurrent events after the first misfortune,” said study author Hanieh Mohammadi from the Karolinska Institute in Sweden.

Prior studies have shown that abdominal obesity is an important risk factor for having a first heart attack. But until now, the association between abdominal obesity and the risk of a subsequent heart attack or stroke was unknown.

The research, published in the European Journal of Preventive Cardiology, followed more than 22,000 patients after their first heart attack and investigated the relation between abdominal obesity (measured by waist circumference) and the risk for recurrent cardiovascular disease events. The researchers specifically looked at events caused by clogged arteries, such as fatal and non-fatal heart attack and stroke.

Heart Attack
Abdominal obesity not only increases your risk for a first heart attack or stroke, but also the risk for recurrent events after the first misfortune. Pixabay

Patients were recruited from the nationwide SWEDEHEART registry and followed for a median of 3.8 years. Most patients — 78 per cent of men and 90 per cent of women — had abdominal obesity (waist circumference 94 cm or above for men and 80 cm or above for women).

Increasing abdominal obesity was independently associated with fatal and non-fatal heart attacks and strokes, regardless of other risk factors (such as smoking, diabetes, hypertension, blood pressure, blood lipids and body mass index [BMI]) and secondary prevention treatments. According to the researchers, waist circumference was a more important marker of recurrent events than overall obesity.

The reason abdominal obesity is very common in patients with a first heart attack is that it is closely linked with conditions that accelerate the clogging of arteries through atherosclerosi, the researchers said. These conditions include increased blood pressure, high blood sugar and insulin resistance (diabetes) as well as raised blood lipid levels.

“Our results, however, suggest that there may be other negative mechanisms associated with abdominal obesity that are independent of these risk factors and remain unrecognised,” Mohammadi said.

“In our study, patients with increasing levels of abdominal obesity still had a raised risk for recurrent events despite being on therapies that lower traditional risk factors connected with abdominal obesity such as anti-hypertensives, diabetes medication and lipid lowering drugs,” she added.

Also Read- New Rule in USA to Allow Passengers to Bring Pet Animals on Flight

According to the study, the relationship between waist circumference and recurrent events was stronger and more linear in men.

“There were three times as many men in the study compared to women, contributing to less statistical power in the female group. Therefore, more studies are needed before definite conclusions can be drawn according to gender,” Mohammadi noted. (IANS)